Since loss of WWP1 causes enhanced levels of LATS1 and decreased tumor cell growth, development of strategies that specifically target WWP1 or disrupt LATS1 and WWP1 interaction in breast cancers to activate LATS1 may be a useful approach for successful cancer therapy. This evidence concerns the gene WWP1 and neoplasm.